Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? 0 03.07.2024 07:08 Economictimes.indiatimes.com Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
